THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Udho Thadani to Isosorbide Dinitrate

This is a "connection" page, showing publications Udho Thadani has written about Isosorbide Dinitrate.
Connection Strength

2.038
  1. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure. Drugs Today (Barc). 2008 Dec; 44(12):925-37.
    View in: PubMed
    Score: 0.319
  2. Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006 Sep; 5(5):667-74.
    View in: PubMed
    Score: 0.273
  3. Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):625-33.
    View in: PubMed
    Score: 0.118
  4. Mononitrates: defining the ideal long-acting nitrate. Clin Ther. 1994 Mar-Apr; 16(2):130-9; discussion 129.
    View in: PubMed
    Score: 0.115
  5. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994 Mar 01; 120(5):353-9.
    View in: PubMed
    Score: 0.115
  6. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214.
    View in: PubMed
    Score: 0.111
  7. Efficacy of isosorbide mononitrate in angina pectoris. Am J Cardiol. 1992 Nov 27; 70(17):67G-71G.
    View in: PubMed
    Score: 0.105
  8. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris. Am J Cardiol. 1992 Aug 01; 70(3):286-92.
    View in: PubMed
    Score: 0.103
  9. Nitrate tolerance. How to prevent it or minimize its effect. Postgrad Med. 1992 Apr; 91(5):307-12, 315-8.
    View in: PubMed
    Score: 0.100
  10. Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates. Clin Pharmacokinet. 1988 Jul; 15(1):32-43.
    View in: PubMed
    Score: 0.077
  11. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol. 1987 Sep 01; 60(7):477-82.
    View in: PubMed
    Score: 0.073
  12. Nitrate therapy: continuous or pulse dosing. Ration Drug Ther. 1987 Jul; 21(7):1-6.
    View in: PubMed
    Score: 0.072
  13. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy. Clin Pharmacol Ther. 1987 Jul; 42(1):58-65.
    View in: PubMed
    Score: 0.072
  14. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Am J Cardiol. 1987 Apr 01; 59(8):756-62.
    View in: PubMed
    Score: 0.071
  15. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris. Z Kardiol. 1985; 74 Suppl 4:21-4.
    View in: PubMed
    Score: 0.061
  16. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 01; 49(2):411-9.
    View in: PubMed
    Score: 0.050
  17. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502.
    View in: PubMed
    Score: 0.045
  18. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation. 1980 Mar; 61(3):526-35.
    View in: PubMed
    Score: 0.043
  19. Chronic stable angina pectoris. Strategies for effective drug therapy. Postgrad Med. 1995 Dec; 98(6):175-6, 179-83, 187-8.
    View in: PubMed
    Score: 0.032
  20. Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):611-23.
    View in: PubMed
    Score: 0.030
  21. Nitrate therapy and the development of tolerance. Arch Fam Med. 1993 Aug; 2(8):880-5.
    View in: PubMed
    Score: 0.028
  22. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance. Herz. 1984 Jun; 9(3):123-36.
    View in: PubMed
    Score: 0.015
  23. Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Br J Clin Pharmacol. 1981 Jun; 11(6):579-89.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES